Literature DB >> 11901295

Activation of the metallothionein IIA promoter and other key stress response elements by ursodeoxycholate in HepG2 cells: relevance to the cytoprotective function of ursodeoxycholate.

C Bernstein1, C M Payne, H Bernstein, H Garewal.   

Abstract

Ursodeoxycholate, used to treat a variety of pathologies, has the ability to reverse cytotoxic and hepatotoxic conditions. We examined HepG2, a hepatic cell line, treated with increasing levels of ursodeoxycholate, for responses of a range of promoters/response elements responsive to DNA damage, heavy metal ions, protein denaturants, aromatic hydrocarbons, retinoids, changes in intracellular AMP levels, end endoplasmic reticulum stress. The metallothionein IIA promoter was the most highly activated by ursodeoxycholate. Since ursodeoxycholate protects against the cytotoxic effects of deoxycholate, our data, combined with observations made by others, implicate metallothionein IIA as being important in this protective pathway. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11901295     DOI: 10.1159/000056179

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  7 in total

1.  Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells.

Authors:  Xiaofang Huo; Stefanie Juergens; Xi Zhang; Davood Rezaei; Chunhua Yu; Eric D Strauch; Jian-Ying Wang; Edaire Cheng; Frank Meyer; David H Wang; Qiuyang Zhang; Stuart J Spechler; Rhonda F Souza
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-02       Impact factor: 4.052

Review 2.  Primary biliary cirrhosis: From bench to bedside.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

3.  Bile acids alter the subcellular localization of CNT2 (concentrative nucleoside cotransporter) and increase CNT2-related transport activity in liver parenchymal cells.

Authors:  Sonia Fernández-Veledo; Isabel Huber-Ruano; Ivette Aymerich; Sylvie Duflot; F Javier Casado; Marçal Pastor-Anglada
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

Review 4.  Bile-acid-induced cell injury and protection.

Authors:  Maria-J Perez; Oscar Briz
Journal:  World J Gastroenterol       Date:  2009-04-14       Impact factor: 5.742

5.  Chemical chaperone, TUDCA unlike PBA, mitigates protein aggregation efficiently and resists ER and non-ER stress induced HepG2 cell death.

Authors:  Jagadeesh Kumar Uppala; Amina R Gani; Kolluru V A Ramaiah
Journal:  Sci Rep       Date:  2017-06-19       Impact factor: 4.379

6.  Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Maria Nadinskaia; Marina Maevskaya; Vladimir Ivashkin; Khava Kodzoeva; Irina Pirogova; Evgeny Chesnokov; Alexander Nersesov; Jamilya Kaibullayeva; Akzhan Konysbekova; Aigul Raissova; Feruza Khamrabaeva; Elena Zueva
Journal:  World J Gastroenterol       Date:  2021-03-14       Impact factor: 5.742

Review 7.  Tauroursodeoxycholate-Bile Acid with Chaperoning Activity: Molecular and Cellular Effects and Therapeutic Perspectives.

Authors:  Magdalena Kusaczuk
Journal:  Cells       Date:  2019-11-20       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.